MoneyWorks4Me

Sanofi India informs about closure of trading window

22 Jun 2023 Evaluate
Pursuant to the Company's Code of Conduct to Regulate, Monitor and Report Insider Trading by Designated Persons, Sanofi India has informed that, for the purpose of declaration of financial results of the Company, for the quarter and half year ended 30th June 2023, the trading window of the Company shall remain closed from 1st July 2023 till 48 hours after the announcement of the results to the stock exchanges.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..